Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for… · FederalPipeline
Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for…
Combined Synopsis/Solicitation from National Institutes of Health, solicitation 75N95026R0007. Responses due Jul 30, 2026. NAICS 541690, No Set aside used. Listed on SAM.gov.